Pilot study of PCNU and cranial radiation therapy in the treatment of patients with malignant gliomas.

Abstract:

:A pilot study was performed administering PCNU with radiation therapy to treat patients with high-grade astrocytomas and to explore the toxic effects of this drug regimen. PCNU at an initial dose of 110 mg/m2 i.v. was administered to 14 patients within 4 weeks after completion of cranial irradiation. Courses were repeated every 6-8 weeks upon recovery from myelosuppression. Radiation therapy consisted of 5,000 rad to the whole brain followed by an additional 1,500 rad to the tumor site. Patients were followed by CT scan and neurologic examination. The median survival for the group was 80 weeks. Larger, randomized trials comparing PCNU to other nitrosoureas will be needed to assess its value as adjuvant therapy in patients with malignant gliomas. Myelosuppression, particularly, thrombocytopenia, was the main toxic effect in this study. Pulmonary infiltrates developed in 2 patients and was progressive and fatal in 1 patient after a total cumulative PCNU dose of 850 mg/m2. Hepatic dysfunction with hyperbilirubinemia also developed in 1 patient. PCNU can produce pulmonary and hepatic toxicity similar to that reported for other nitrosoureas. Regular monitoring of pulmonary and hepatic function tests should be performed during treatment with PCNU in future trials.

journal_name

Oncology

journal_title

Oncology

authors

Feun LG,Maor M,Stewart DJ,Leavens ME,Savaraj N,Bodey GP

doi

10.1159/000226854

subject

Has Abstract

pub_date

1990-01-01 00:00:00

pages

389-92

issue

5

eissn

0030-2414

issn

1423-0232

journal_volume

47

pub_type

杂志文章

相关文献

ONCOLOGY文献大全
  • TC21/R-Ras2 upregulation in esophageal tumorigenesis: potential diagnostic implications.

    abstract:OBJECTIVES:Early detection of esophageal cancer is hampered by paucity of molecular markers for diagnosis of this aggressive gastrointestinal malignancy in early stages. We recently identified TC21/R-Ras2, a small GTP-binding protein (SMG) in esophageal squamous cell carcinomas (ESCCs) by differential display. This stu...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000087283

    authors: Sharma R,Sud N,Chattopadhyay TK,Ralhan R

    更新日期:2005-01-01 00:00:00

  • Preoperatively irradiated rectal carcinoma: analysis of the histopathologic response and predictive value of proliferating cell nuclear antigen immunostaining.

    abstract:OBJECTIVES:To investigate the relationship between the histopathologic effects of preoperative chemoradiotherapy in rectal cancer and the proteins, proliferating cell nuclear antigen (PCNA) and p53. METHODS:Samples from 73 tumors were examined. The histopathologic effects observed in the resected specimens induced by ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000069307

    authors: Díez M,Ramos P,Medrano MJ,Mugüerza JM,Villeta R,Lozano O,Escribano J,Noguerales F,Ruíz A,Granell J

    更新日期:2003-01-01 00:00:00

  • Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.

    abstract:AIM:The aim of this study was to assess the molecular subtype profiles of male breast cancer (MBC) and subsequent clinical outcome using a validated 6-marker immunohistochemical panel. METHODS:A total of 43 cases of MBC were examined retrospectively using a semiquantitative immunohistochemical analysis of estrogen rec...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000341537

    authors: Sánchez-Muñoz A,Román-Jobacho A,Pérez-Villa L,Sánchez-Rovira P,Miramón J,Pérez D,Sáez MI,de Luque V,Medina L,Ramírez-Tortosa CL,Vicioso L,Medina JA,Ribelles N,Alba E

    更新日期:2012-01-01 00:00:00

  • Intermittent chemotherapy is a treatment choice for advanced urothelial cancer.

    abstract:OBJECTIVE:To investigate the potential benefit of intermittent chemotherapy, and to identify the eligibility criteria offering intermittent chemotherapy to patients with advanced urothelial cancer. MATERIALS AND METHODS:Twenty patients who responded or had stable disease after receiving 3 cycles of induction chemother...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章

    doi:10.1159/000338770

    authors: Onishi T,Sasaki T,Hoshina A

    更新日期:2012-01-01 00:00:00

  • The Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 and the risk of colorectal cancer.

    abstract:OBJECTIVE:The purpose of this study is to investigate whether the Ile646Val (2073A>G) polymorphism in the kinase-binding domain of A-kinase anchoring protein 10 (AKAP10) is related to the risk of colorectal cancer (CRC), clinicopathological variables and the environmental factors for the development of CRC. METHODS:Ap...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000201572

    authors: Wang MJ,Zhou ZG,Wang L,Yu YY,Zhang P,Zhang Y,Cui CF,Yang L,Li Y,Zhou B,Sun XF

    更新日期:2009-01-01 00:00:00

  • Birth defects in three common pediatric malignancies; Wilms' tumor, neuroblastoma and Ewing's sarcoma.

    abstract::During the period 1965-1980, 84 patients with Wilms' tumor, neuroblastoma and Ewing's sarcoma were treated at the University of Rochester Medical Center. All patients were evaluated for the presence of congenital abnormalities. Ten of 34 (29%) patients with Wilms' tumor, 3 of 32 (9%) patients with neuroblastoma, and 0...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226064

    authors: Nakissa N,Constine LS,Rubin P,Strohl R

    更新日期:1985-01-01 00:00:00

  • Ondansetron: a cost-effective advance in anti-emetic therapy.

    abstract::A cost-effectiveness analysis is one form of full economic evaluation where drug acquisition costs and the costs that are incurred as a result of using a particular treatment are assessed together with clinical efficacy. This paper reviews two such studies. One of the studies was a prospective randomised cost-effectiv...

    journal_title:Oncology

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000227175

    authors: Cox F,Hirsch J

    更新日期:1993-05-01 00:00:00

  • Clear cell renal cell carcinoma associated with bilateral atypical acute posterior multifocal placoid pigment epitheliopathy.

    abstract:BACKGROUND/OBJECTIVE:Clear cell renal cell carcinoma (CCRCC) is a malignant neoplasm frequently associated with an increase in circulating immune complexes (CIC). Acute posterior multifocal placoid pigment epitheliopathy (APMPPE) is a disease involving the chorioretinal structures of the eye, and it is commonly observe...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000079505

    authors: Parmeggiani F,Costagliola C,D'Angelo S,Incorvaia C,Perri P,Sebastiani A

    更新日期:2004-01-01 00:00:00

  • Stem cell relationships and the origin of gastrointestinal cancer.

    abstract::Gastrointestinal stem cells have the capacity for long-term self-replication and the ability to give rise to all other epithelial cell lineages. These properties make them essential since they maintain tissue homeostasis by regulating cell turnover depending on the current demand. However, they are also important play...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000086625

    authors: Schier S,Wright NA

    更新日期:2005-01-01 00:00:00

  • A New Transcutaneous Method for Breast Cancer Detection with Dogs.

    abstract::We developed a new transcutaneous method for breast cancer detection with dogs: 2 dogs were trained to sniff skin secretion samples on compresses that had been worn overnight by women on their breast, and to recognize a breast cancer sample among 4 samples. During the test, the dogs recognized 90.3% of skin secretion ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000492895

    authors: Thuleau A,Gilbert C,Bauër P,Alran S,Fourchotte V,Guillot E,Vincent-Salomon A,Kerihuel JC,Dugay J,Semetey V,Kriegel I,Fromantin I

    更新日期:2019-01-01 00:00:00

  • Overcoming Tamoxifen Resistance by Regulation of Del-1 in Breast Cancer.

    abstract:BACKGROUND:Hormone receptor-positive breast cancer accounts for nearly two-thirds of breast cancer cases; it ultimately acquires resistance during endocrine treatment and becomes more aggressive. This study evaluated the role of developmental endothelial locus (Del)-1 in tamoxifen-resistant (TAM-R) breast cancer. METH...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000501340

    authors: Lee J,Jeong JH,Jung JH,Kim WW,Lee SJ,Park JY,Park JY,Kang SH,Kim EA,Park JH,Chae YS,Park HY

    更新日期:2019-01-01 00:00:00

  • Radioimmunoimaging in malignant melanoma with monoclonal antibodies.

    abstract::Twenty-five patients with cutaneous melanoma were imaged with F(ab')2 fragments of antimelanoma monoclonal antibody (MoAb) 225.28S labeled with 99mTc and 131I or 111In. Out of 16 patients without evidence of metastatic lesions, 6 false-positive cases were observed. Only 4 out of 9 patients with known lesions showed po...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226649

    authors: Repetto L,Scopinaro G,Michelotti A,Claudiani F,Fusco V,Grimaldi A,Sertoli MR,Rosso R

    更新日期:1988-01-01 00:00:00

  • Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.

    abstract:OBJECTIVES:18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is useful for differentiating benign from malignant lesions, evaluating tumor stage, monitoring the response to therapy and detecting tumor recurrence in a variety of malignancies. Nevertheless, its use in patients with hepatocellular carcinoma (H...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000111715

    authors: Yoon KT,Kim JK,Kim DY,Ahn SH,Lee JD,Yun M,Rha SY,Chon CY,Han KH

    更新日期:2007-01-01 00:00:00

  • Differences in cellular proteins between high and low metastatic potential sublines from the methylcholanthrene-induced rat fibrosarcoma cell line.

    abstract::The purpose of the present study was to determine with two-dimensional electrophoresis whether two sublines (high and low metastatic potential to lymph nodes) of rat fibrosarcoma induced by methylcholanthrene have differences in cellular proteins. The high metastatic potential subline had a specific protein in the pro...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227028

    authors: Minato K,Manabe T,Okuyama N,Sasaki Y,Nakagawa K,Saijo N

    更新日期:1992-01-01 00:00:00

  • Expression of vascular endothelial growth factor D is associated with lymph node metastasis in human colorectal carcinoma.

    abstract:OBJECTIVE:Expression of vascular endothelial growth factor (VEGF)-D by tumors is associated with metastasis to lymph nodes in mice. However, there are few reports concerning the clinical significance of VEGF-D protein in human carcinoma. METHODS:After confirming production of VEGF-D by eight colorectal carcinoma cell ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000070301

    authors: Funaki H,Nishimura G,Harada S,Ninomiya I,Terada I,Fushida S,Tani T,Fujimura T,Kayahara M,Shimizu K,Ohta T,Miwa K

    更新日期:2003-01-01 00:00:00

  • Frequent occurrence of abnormal E-cadherin/beta-catenin protein expression in advanced gallbladder cancers and its association with decreased apoptosis.

    abstract:OBJECTIVE:Our aim is to assess the clinicopathological significance of E-cadherin and beta-catenin expression, as well as their association with apoptosis in gallbladder cancers. METHODS:The expression of E-cadherin and beta-catenin proteins was examined in 4 biliary tract cancer cell lines and 49 gallbladder cancer s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000100478

    authors: Hirata K,Ajiki T,Okazaki T,Horiuchi H,Fujita T,Kuroda Y

    更新日期:2006-01-01 00:00:00

  • Lipid metabolism and liver disease in hepatitis C viral infection.

    abstract::Persistent infection with hepatitis C virus (HCV) is a major risk toward development of hepatocellular carcinoma. A number of transgenic mouse lines carrying the cDNA of HCV genome have been established and evaluated in the study of HCV pathogenesis. Among those, the studies using transgenic mouse lines that carry the...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000315226

    authors: Koike K,Tsutsumi T,Yotsuyanagi H,Moriya K

    更新日期:2010-07-01 00:00:00

  • Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.

    abstract::A total of 103 patients with lung cancer was treated with CCNU 130 mg/m2 orally every 6 weeks; 65 patients survived at least 6 weeks. Partial responses occurred in 7 patients. Leukopenia, thrombocytopenia, and nausea were frequent toxic effects. CCNU has slight efficacy in advanced lung cancer. No increase in survival...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225035

    authors: Stolinsky DC,Bull FE,Pajak TF,Bateman JR

    更新日期:1975-01-01 00:00:00

  • The role of neck dissection after radical chemoradiation for locally advanced head and neck cancer: should we move back?.

    abstract::Until a few decades ago neck dissection (ND) was the standard surgical approach for node-positive tumours. Nowadays patients with locally advanced head and neck cancer can be treated with definitive chemoradiation (CRT), which includes the treatment of the neck; however, results on residual viable tumour after conserv...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000346132

    authors: Denaro N,Russi EG,Numico G,Pazzaia T,Vitiello R,Merlano MC

    更新日期:2013-01-01 00:00:00

  • Phase-I clinical trial of sodium cyanate in patients with advanced colorectal carcinoma.

    abstract::Sodium cyanate, a drug that selectively suppresses amino acid incorporation for protein synthesis in tumor tissue, was given to patients with advanced colorectal carcinoma who had failed to conventional therapy, with the purpose of assessing a maximum tolerable oral dose. At 35 mg/kg p.o. daily, the drug had to be sto...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226038

    authors: Herrera-Ornelas L,Petrelli NJ,Madajewicz S,Mittelman A,Allfrey VG

    更新日期:1985-01-01 00:00:00

  • Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

    abstract::This study sought to examine the relationship between MUC1 expression at the deepest invasive portion, invasive/metastatic potential, and prognosis of colorectal cancer in relation to cellular proliferation. MUC1 expression was detected immunohistochemically using KL-6 antibody (anti-MUC1 monoclonal antibody) in 100 s...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000011868

    authors: Hiraga Y,Tanaka S,Haruma K,Yoshihara M,Sumii K,Kajiyama G,Shimamoto F,Kohno N

    更新日期:1998-07-01 00:00:00

  • Platelet-mimicry of cancer cells: epiphenomenon with clinical significance.

    abstract::Stem cell mimicry of cancer cells has been known for a long time and is considered to be responsible for ectopic gene expressions. The stem cell characteristics of tumor cells are shown to be involved in epithelial-mesenchymal transition and in the phenomenon of vascular mimicry. Certain cancer types acquire a geno-ph...

    journal_title:Oncology

    pub_type: 杂志文章,评审

    doi:10.1159/000088069

    authors: Tímár J,Tóvári J,Rásó E,Mészáros L,Bereczky B,Lapis K

    更新日期:2005-01-01 00:00:00

  • Latent coagulation disorders evaluated by the assay of plasma thrombin-antithrombin III complexes in a large series of 'solid tumours'.

    abstract::Coagulation disorders are frequently detected in patients affected by different tumours even though clinical symptoms occur in a very small percentage of such subjects. Coagulation processes are probably involved in the mechanism of metastatic spread. We assayed the plasma levels of thrombin-antithrombin III (TAT) com...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227086

    authors: Bartoloni C,Guidi L,Tricerri A,Patriarca F,Pili R,Cursi F,Canetta M,Cappelli A,Vangeli M,Salvati F

    更新日期:1992-01-01 00:00:00

  • A new formula for predicting liver metastasis in patients with colorectal cancer: immunohistochemical analysis of a large series of 439 surgically resected cases.

    abstract:OBJECTIVE:The purpose of this study was to establish a new formula predicting liver metastasis in patients with colorectal cancer (CRC). METHODS:Nine previously reported predictive markers for liver metastasis and/or prognosis (COX-2, dysadherin, E-cadherin, beta-catenin, Ki-67, p53, laminin5gamma2, matrilysin and MUC...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151667

    authors: Ochiai H,Nakanishi Y,Fukasawa Y,Sato Y,Yoshimura K,Moriya Y,Kanai Y,Watanabe M,Hasegawa H,Kitagawa Y,Kitajima M,Hirohashi S

    更新日期:2008-01-01 00:00:00

  • Reevaluation of C-reactive protein in cancer sera by radioimmunoassay and radial immunodiffusion. I. Diagnostic value and use in battery of conventional tumor markers.

    abstract::C-reactive protein (CRP) has been found to be ubiquitous in sera when determined by a highly sensitive methods such as radioimmunoassay. Patients with some tumors appear to have much higher serum levels of CRP than others; in these, CRP seems to reflect the tumor burden. There is a positive correlation with TNM stagin...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000225572

    authors: Drahovsky D,Dunzendorfer U,Ziegenhagen G,Drahovsky M,Kellen JA

    更新日期:1981-01-01 00:00:00

  • A demonstration project on cancer screening in rural Thailand: preliminary report.

    abstract::A demonstration multiphasic cancer screening program was conducted in a rural village in Thailand under the coordination of Bangkok's National Cancer Institute. The village's physician, mayor, and other members of the community assumed a variety of volunteer roles in order to provide logistical support. In short, this...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000226029

    authors: Lynch HT,Pitakspraiwan P,Sombooncharoen S,Phanthumchinda P,Vechmon U,Srivanwat G,Schutz RJ,Lynch JF

    更新日期:1985-01-01 00:00:00

  • Second-line chemotherapy in recurrent clear cell ovarian cancer: results from the multicenter italian trials in ovarian cancer (MITO-9).

    abstract:BACKGROUND AND AIMS:Ovarian clear cell carcinoma (CCC) has a poorer prognosis than other subtypes of ovarian cancer. In this study, we evaluated the responsiveness to second-line chemotherapy in recurrent ovarian CCC. METHODS:The MITO-9 project investigated a cohort of patients observed between 1991 and 2007 in 20 cen...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000358730

    authors: Esposito F,Cecere SC,Magazzino F,Katsaros D,Ottaiano A,Gadducci A,Pisano C,Scalone S,Rabaiotti E,Salutari V,Cormio G,Canuto EM,Greggi S,Savarese A,Marinaccio M,Scollo P,Santeufemia DA,Sacco C,Facchini G,Pignata S

    更新日期:2014-01-01 00:00:00

  • Tumor-Infiltrating Lymphocytes in Biopsy Specimens Obtained 7 Days after Starting Chemoradiotherapy for Rectal Cancer Are Predictors of the Response to Chemoradiotherapy.

    abstract:BACKGROUND:Neoadjuvant chemoradiotherapy (nCRT) followed by total mesorectal excision surgery is a standard treatment for locally advanced rectal cancer (LARC). Tumor-infiltrating lymphocytes (TILs) have been reported to be associated with tumor response; however, this remains to be established. We previously reported ...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000508922

    authors: Miyakita H,Sadahiro S,Suzuki T,Chan LF,Ogimi T,Okada K,Yamamoto S,Kajiwara H

    更新日期:2020-01-01 00:00:00

  • Prospective comparison of sorafenib and sunitinib for second-line treatment of cytokine-refractory kidney cancer patients.

    abstract:OBJECTIVES:It was the aim of this study to investigate the clinical differences between the tyrosine kinase inhibitors (TKIs) sorafenib and sunitinib as second-line treatment for cytokine-refractory kidney cancer patients. METHODS:Twenty consecutive patients received continuous treatment of oral sorafenib at a dose of...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000151369

    authors: Herrmann E,Bierer S,Gerss J,Köpke T,Hertle L,Wülfing C

    更新日期:2008-01-01 00:00:00

  • Testing prospective anticancer drugs against human tumors using simple in vivo models.

    abstract::The activities of established and experimental antitumor drugs were tested against the BRO and MeWo human melanomas transplanted in the subrenal capsule of phenotypically immunocompetent (CBA x C57BL/6)F1 mice. Immunosuppression was achieved with preliminary whole-body radiation, and cytological examination showed tha...

    journal_title:Oncology

    pub_type: 杂志文章

    doi:10.1159/000227400

    authors: Ryabkova VI,Lockshin A,Strukov IG,Sokolova VK

    更新日期:1994-11-01 00:00:00